Toxic epidermal necrolysis future or investigational therapies

Revision as of 16:04, 15 August 2018 by Irfan Dotani (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Toxic epidermal necrolysis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Epidermal Necrolysis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic epidermal necrolysis future or investigational therapies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic epidermal necrolysis future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic epidermal necrolysis future or investigational therapies

CDC on Toxic epidermal necrolysis future or investigational therapies

Toxic epidermal necrolysis future or investigational therapies in the news

Blogs on Toxic epidermal necrolysis future or investigational therapies

Directions to Hospitals Treating Toxic epidermal necrolysis

Risk calculators and risk factors for Toxic epidermal necrolysis future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Future or Investigational Therapies

References

Template:WH Template:WS